Deloitte Survey: Life Sciences Confidence Rises at Company Level, Despite External Considerations
Summary
Life sciences executives are showing stronger confidence in their own companies than in the broader economy. They are keeping R&D as the top spending priority while increasing AI and digital investment at the same pace. The report highlights a gap between rapid AI deployment and limited proof of business value, which is pushing leaders to define KPIs and measure outcomes more rigorously. Partnerships are becoming more important for accessing AI capabilities and supporting innovation, pipeline development, and commercial execution. Companies are also adjusting productivity initiatives, operating footprints, and portfolio choices to stay resilient in a more uncertain environment.
Classifications
industries
No industries detected
applications
Business Intelligence
AskAI Classifications
Labels
No AI classifications detected
Linked Companies
DNM
$1M to $5M